FDA - Food and Drug Administration

Israeli pride: Phytolon receives FDA approval – sparks significant interest in the U.S.

Millennium FoodTech R&D Partnership: Portfolio company Phytollon, which develops natural and innovative food colorings, received FDA approval to market its first product in the U.S.

Portfolio company Phytoon, which develops natural and innovative food colorings, received FDA approval to market its first product in the U.S
(Illustrative) A doctor uses AI for a medical screening.

FDA clears AI model to triage urgent CT findings, Israeli firm says

ENDOART, A synthetic endothelial layer for the treatment of chronic corneal edema.

FDA clears first US trial of Israel’s EndoArt synthetic corneal implant

 Dividing cancer cell

Arizona couple admits in court to faking cancer-curing 'smart chip' device


BioGenCell raises $16m. for chronic disease treatment

The company’s treatment has already prevented loss of limb in several patients during Phase I trials.

 Microglia (green) that were “matured” in the lab from stem cells of ALS patients; the cells’ nuclei are in blue. Viewed with confocal microscopy

Biogen pulls application for Alzheimer's drug in Europe

The drugmaker said the move follows interactions with the European Medicines Agency that suggested data provided so far would not be enough to support an approval.

A sign marks a Biogen facility, some of whose employees have tested positive for the coronavirus after attending a meeting in Boston, in Cambridge, Massachusetts, US, March 9, 2020.

Japan's Kowa says Ivermectin showed 'antiviral effect' against Omicron

Clinical trials are ongoing, but promotion of ivermectin as a COVID-19 treatment has generated controversy.

Ivermectin

Biogen shares slide as Medicare restricts cover of Alzheimer's treatments

The coverage decision by US Centers for Medicare and Medicaid Services (CMS), the health agency that runs Medicare, crushes any hopes of the drug Aduhelm gaining traction.

Aduhelm, Biogen's controversial recently approved drug for early Alzheimer's disease, is seen at Butler Hospital, one of the clinical research sites in Providence, Rhode Island, US, June 16, 2021.

Wait 3 days, then swab throat and nose when using antigen test, Health Ministry says

The Health Ministry published new recommendations on how to use the at-home kits, amid criticism for their lack of accuracy.

 Meuhedet Health care worker wearing protective gear takes swab samples from a woman, at Meuhedet coronavirus testing center in Jerusalem, January 6, 2022.

Controversial Alzheimer's drug administered for first time in Israel

This marks the first time that the drug has been used outside of the United States.

 Dr. Bergman, the first patient Jeremiah Kozari and Dr. Shiner.

Israeli firm SpliSense moves to clinical trials for cystic fibrosis treatment

"It will improve patients' lung function, reduce lung inflammation, enable them to breathe better, and go back to normal life."

 Treating Cystic Fibrosis (illustrative).

US FDA clears Pfizer's COVID-19 booster shot for 12- to 15-year-olds

The FDA said it reviewed published data and real-world evidence on the safety of booster doses provided by the Israeli Ministry of Health.

An illustrative photo of the Pfizer COVID-19 vaccine.

US authorizes German Firm's at-home COVID-19 test

The approval comes at a time when companies such as Walmart Inc, Walgreens Boots Alliance and CVS Health Corp have limited sales of at-home COVID-19 testing kits as demand surged.

Israeli receiving a COVID test at Meuhedet Health Maintenance Organization center in Jerusalem on August 11, 2021.

Roche's at home covid test kit gets emergency FDA approval

The test, which uses a anterior nasal swab sample, is 'able to produce accurate, reliable and quick results in as few as 20 minutes' for SARS-CoV-2 and all variants of concern.

A box of material for rapid COVID-19 antigenic tests made by Swiss drugmaker Roche is pictured at the University Hospital (CHUV) during the coronavirus disease (COVID-19) outbreak in Lausanne, Switzerland, November 13, 2020.